DHI vs HAE · P/E 9.6, rev $34.25B vs P/E 35, rev $1.33B
DR Horton Inc (DHI) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the DHI and HAE stock pages for the full models.
Not investment advice.